Nihon Kohden (NHNKY) Expected to Post Quarterly Earnings on Wednesday

Posted by John Perry on Jul 29th, 2026

Nihon Kohden (OTCMKTS:NHNKY – Get Free Report) will likely be posting its resultson Wednesday, August 5th. Analysts expect Nihon Kohden to post earnings of $0.06 per share and revenue of $299.9750 million for the quarter.

Nihon Kohden (OTCMKTS:NHNKY – Get Free Report) last issued its earnings results on Thursday, May 14th. The company reported $0.34 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.24 by $0.10. The firm had revenue of $453.10 million during the quarter, compared to analyst estimates of $414.40 million. Nihon Kohden had a net margin of 6.08% and a return on equity of 9.46%. On average, analysts expect Nihon Kohden to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Nihon Kohden Trading Up 1.6%

OTCMKTS NHNKY opened at $9.86 on Wednesday. The stock has a market cap of $1.66 billion, a PE ratio of 16.71 and a beta of 0.39. Nihon Kohden has a 12 month low of $8.12 and a 12 month high of $14.21. The company’s 50-day moving average price is $9.04 and its 200-day moving average price is $9.85.

Wall Street Analysts Forecast Growth

Separately, Zacks Research raised shares of Nihon Kohden to a “hold” rating in a report on Monday, April 27th. One investment analyst has rated the stock with a Strong Buy rating and one has assigned a Hold rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Buy”.

Get Our Latest Research Report on NHNKY

Nihon Kohden Company Profile

(Get Free Report)

Nihon Kohden Corporation is a Tokyo-based manufacturer of medical electronic equipment, founded in 1951. The company has built a reputation for innovation in patient monitoring and diagnostic systems, developing one of Japan’s earliest electrocardiogram (ECG) machines and pioneering transistor-based oscilloscopes for clinical use. Over the decades, Nihon Kohden has expanded its product portfolio to address a wide range of healthcare needs, from emergency response to intensive care and neurology.

The company’s core offerings include patient monitors, ECG and electroencephalograph (EEG) devices, defibrillators, infusion pumps, and neuromonitoring systems.